(415) 353-2318 (appts)
(415) 476-0659 (fax)

Box 0538, UCSF; San Francisco, CA 94143-0538

additional websites:

UCSF Physician Referral Directory

University of Alberta, MD, 1984-87
University of Toronto, FRCPC, 1988-92, Internal Medicine
University of Toronto, FRCPC, 1992-94, Gastroenterology
University of California, Berkeley, MPH, 1996-97, Epidemiology

Terrault NA, Combs C, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alpha for the treatment of recurrent hepatitis B following liver transplantation. Liver Transplant Surg, 1996;2:132-8.

Zhou S, Terrault NA, Ferrell L, Hahn, J, Simmonds P, Lau JYN, Roberts JP, Lake, JR, Ascher NL, Wright TL. Severity of Liver Disease in Liver Transplant Recipients with Hepatitis C Virus Infection: Relationship to Genotype and Level of Viremia. Hepatology 1996;24:1041-6. (First and second authors contributed equally)

Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology, 1996; 111:1569-75.

Terrault NA, Dailey PJ, Ferrell L, Collins MC, Wilber JC, Urdea MS, Bhandari BN, Wright TL. Hepatitis C virus: Quantitation and distribution in liver. J Med Virol 1997; 51:217-224. First and second authors contributed equally.

Pessoa MG, Terrault NA, Ferrell L, Kim JP, Kolberg J, Detmer J, Collins M, Yun A, Lake JR, Roberts JP, Ascher NL, Wright TL. Detection of quantitation of hepatitis G virus (HGV) in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997:25:1266-70.

Ishitani M, MdGory R, Dickson R, Caldwell S, Bickston S, McCullough S, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake, J. Retransplantation of patients with severe post-transplnt hepatitis B in the first allograft. Transplantation 1997;64:410-4.

Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins ML, Hassoba H, Wright TL. Quantitation of hepatitis G virus and hepatitis C virus in the liver: Evidence that HGV is not a hepatropic virus. Hepatology 1998;27:877-80.

Hossaba H, Terrault NA, El-Gohary A, Scheffel C, Jou C, Brackett J, Hunt J, Lou S, Wright TL. Antibody to GBV-C second envelop glycoprotein (Anti GBV-C E2): is it a marker of immunity? J Med Virol 1997;53:354-60.

Taga S, Washington MK, Terrault NA, Wright, TL, Somberg, K, Ferrell L. Cholestatic hepatitis C in liver allografts. Liver Tranpl Surg 1998, in press.

Terrault NA, Zhou, S, McGory R, Pruett T, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, 1998;28:555-61.

Pessoa MG, Terrault NA, Ferrell L, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis following liver transplantation: Role of known and unknown viruses. Liver Transpl Surg 1998;4:461-68.

Terrault NA. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection? Hepatology, 2000 Sep, 32(3):675-7.

Terrault NA, Ma Mang. Adding to the Hepatitis B Virus Arsenal: Alpha Glucosidase Inhibitor Derivatives. Hepatology 2001:33(6):1544-6..

Yao, FY, Terrault NA, Friese C, Maslow L, Bass NM. Lamivudine reduces the need for liver transplantation and improves survival in patients with severely decompensated cirrhosis with actively replicating hepatitis B infection: A controlled study. Hepatology 2001:24:411-6

Teo EK, Han S, Terrault N, Luketic V, Jensen D, Keeffe E, Lok ASF. Liver transplantation for hepatitis B patients: Do Asians fare worse than Whites? Hepatology 2001:34:126-32.

Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton M. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl. 2002;8(4):350-5.

Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O'Connor KJ, Roth D, Terrault NA, Henry ML. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002 Dec 27;74(12):1657-6.

Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV.A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003 Mar 24;163(6):728-3

Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg E, French AL, Robison E, Nowicki M, Terrault N. Incident Hepatitis C Virus Infection in Women with HIV: A Report from the WomenÍs Interagency HIV Study. JAIDS 2003;15;37(10):1357-64.

Schiff ER, Lai CL, Hadziyannis S, Neuhaus, P, Terrault NA, Colombo M, Tillmann H, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003;38(6):1419-27.

Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27;76(2):370-5.

Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R, Valsamakis A, Terrault N. Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT¬ HCV RNA 3.0 Assay (bDNA). J. Clin Microbiol 2004;42(2):563-569.

A. French, L Benning, K Anastos, M Augenbaum, M Nowicki, K. Sathasivam, NA Terrault. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: Impact of hepatitis C coinfection. Clin Infect Dis, 2004, in press.

NATerrault, JM Pawlotsky, J McHutchison, F Anderson, M Krajden, S Gordon, I Zitron, R Perrillo, R Gish, M Holodniy, M Friesenhahn Clinical Utility of Viral Load Measurements in Individuals with Chronic Hepatitis C Infection on Antiviral Therapy. J Viral Hepatitis, 2004: in press.

A.K. Shergill, M. Khalili, S. Straley, K. Bollinger, J.P. Roberts, N.A. Ascher, NA. Terrault. Applicability and tolerability of preemptive antiviral therapy in hepatitis C infected liver transplant recipients. Am J. Transplant, 2004, in press.

D Patel, NA Terrault, FY Yao, NM Bass, U Ladabaum. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol, 2004, in press.

3/15/05